To further confirm the potential prognostic value of FSCN family in MM, age (≥ 60 vs. < 60 years), gender, albumin (ALB), B2M, HGB, LDH, expression levels of FSCN1-3 and other common genetic mutations (CCND1, FGFR3, LIG4, and TP53) were included in univariate and multivariate cox regression analysis. The gene discussed is TP53; the disease is Miyoshi myopathy.